X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
middle aged (109) 109
female (99) 99
male (97) 97
aged (95) 95
adult (81) 81
oncology (80) 80
index medicus (48) 48
aged, 80 and over (45) 45
cancer (40) 40
article (30) 30
prognosis (29) 29
adolescent (28) 28
retrospective studies (28) 28
treatment outcome (26) 26
hematology (23) 23
surgery (23) 23
survival rate (22) 22
carcinoma (20) 20
child (19) 19
adenocarcinoma (18) 18
chemotherapy (18) 18
expression (18) 18
survival analysis (18) 18
disease-free survival (17) 17
multivariate analysis (17) 17
hematology, oncology and palliative medicine (15) 15
immunohistochemistry (15) 15
survival (15) 15
transplantation (15) 15
dna methylation (14) 14
pathology (14) 14
prostate cancer (14) 14
tumors (14) 14
care and treatment (13) 13
neoplasm staging (13) 13
obstetrics & gynecology (13) 13
child, preschool (12) 12
follow-up studies (12) 12
proportional hazards models (12) 12
research (12) 12
risk factors (12) 12
therapy (12) 12
young adult (12) 12
cyclophosphamide (11) 11
disease progression (11) 11
head and neck neoplasms - genetics (11) 11
prostatic neoplasms - pathology (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
carcinoma, squamous cell - genetics (10) 10
combined modality therapy (10) 10
cyclophosphamide - administration & dosage (10) 10
ovarian cancer (10) 10
progression (10) 10
prospective studies (10) 10
radiotherapy (10) 10
analysis (9) 9
immunology (9) 9
mortality (9) 9
mutations (9) 9
ovarian neoplasms - surgery (9) 9
prostatic neoplasms - drug therapy (9) 9
abridged index medicus (8) 8
adenocarcinoma - pathology (8) 8
animals (8) 8
biomarkers, tumor - genetics (8) 8
bone marrow transplantation - adverse effects (8) 8
diagnosis (8) 8
dose-response relationship, drug (8) 8
infant (8) 8
logistic models (8) 8
lung-cancer (8) 8
obstetrics and gynecology (8) 8
polymerase chain reaction (8) 8
solid tumors (8) 8
time factors (8) 8
adenocarcinoma - metabolism (7) 7
adenocarcinoma - mortality (7) 7
bone marrow (7) 7
bone-marrow-transplantation (7) 7
carcinoma, squamous cell - mortality (7) 7
cell line, tumor (7) 7
cells (7) 7
disease (7) 7
dna (7) 7
gene expression regulation, neoplastic (7) 7
head and neck cancer (7) 7
mice (7) 7
otorhinolaryngology (7) 7
p53 (7) 7
prostate-specific antigen - blood (7) 7
stem-cell transplantation (7) 7
transplantation, homologous (7) 7
urology & nephrology (7) 7
women (7) 7
acute myeloid-leukemia (6) 6
antigen (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
carcinoma, squamous cell - pathology (6) 6
carcinoma, squamous cell - therapy (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 05/2017, Volume 66, Issue 5, pp. 794 - 801
ObjectiveRecent data supports a significant role for immune checkpoint inhibitors in the treatment of solid tumours. Here, we evaluate gastric and... 
CARCINOMA PATIENTS | METASTASIS | MOLECULE | ANTIBODY | B7-H1 | PROGNOSTIC-SIGNIFICANCE | INDUCTION | GASTROENTEROLOGY & HEPATOLOGY | CANCER | PROGRAMMED DEATH-1 LIGAND-1 | LYMPHOCYTES | Adenocarcinoma - pathology | Humans | Middle Aged | DNA, Viral - analysis | Male | Stomach Neoplasms - pathology | Young Adult | Lymphocytes, Tumor-Infiltrating | Aged, 80 and over | Adult | Esophagogastric Junction - immunology | Female | Stomach Neoplasms - chemistry | Adenocarcinoma - chemistry | Esophagogastric Junction - virology | Stomach Neoplasms - virology | Neoplasm Invasiveness | Adenocarcinoma - immunology | Esophagogastric Junction - pathology | Survival Rate | B7-H1 Antigen - genetics | Adenocarcinoma - virology | Herpesvirus 4, Human | Stomach Neoplasms - immunology | Disease-Free Survival | Aged | B7-H1 Antigen - analysis | Esophagogastric Junction - chemistry | CD8-Positive T-Lymphocytes - immunology | Care and treatment | T cells | Stomach cancer | Immunity | Analysis | Immunohistochemistry | Cell survival | Dendritic cells | CD8 antigen | Stroma | Systematic review | Lymphocytes T | Hybridization | Patients | Cancer therapies | Esophagus | Cell adhesion & migration | Cell density | Metastases | Immune checkpoint | Lymphocytes | Medical prognosis | PD-L1 protein | Ligands | Solid tumors | Deoxyribonucleic acid--DNA | Tumors | Apoptosis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
Journal Article
Transfusion, ISSN 0041-1132, 07/2016, Volume 56, Issue 7, pp. 1750 - 1757
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4027 - 4034
Purpose: Pazopanib, a multireceptor tyrosine kinase inhibitor targeting primarily VEGFRs1-3, is approved for advanced soft tissue sarcoma (STS) and renal cell... 
EWINGS-SARCOMA | CELLS | SOLID TUMORS | ONCOLOGY | PATHWAY | THYROID-CANCER | PALETTE | GROWTH | RHABDOMYOSARCOMA | RESISTANCE | SORAFENIB | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Pyrimidines - administration & dosage | Humans | Middle Aged | Pyrimidinones - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Sarcoma - drug therapy | Sarcoma - pathology | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Pyridones - administration & dosage | Drug-Related Side Effects and Adverse Reactions | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Adult | Female | Aged | Pyrimidinones - administration & dosage | Sarcoma - genetics | MAP Kinase Kinase Kinase 1 - antagonists & inhibitors | Pyridones - adverse effects | Sulfonamides - administration & dosage | Rhabdomyosarcoma | Raf protein | Synergism | Metastases | Confidence intervals | Safety engineering | Vascular endothelial growth factor | Protein-tyrosine kinase | Tyrosine | Kidneys | Sarcoma | Melanoma | Soft tissue sarcoma | Diarrhea | Fatigue | Nausea | Disease control | Survival | Patients | Vascular endothelial growth factor receptors | Inhibitors | Experimental design | Aberration | Clear cell-type renal cell carcinoma | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2019, Volume 37, Issue 4_suppl, pp. 267 - 267
Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2017, Volume 116, Issue 11, pp. 1402 - 1407
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 06/2019
Differentiated thyroid cancer (DTC) responds to VEGF receptor inhibitors. VEGF signals through RAS/RAF/MEK signaling. We evaluated the safety and efficacy of... 
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 5, p. e10828
Journal Article